2-[2-{phenylamino}-1H-pyrrolo[2,3-D]pyrimidin-4-yl)amino] benzamide derivatives as IGF-1R inhibitors for the treatment of cancer
US7981903B2 · kind B2 · utility
2Cited by
0References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 6, 2008 |
| Grant date | Jul 19, 2011 |
| Priority date | — |
| Expiry date | Aug 6, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novel pyrrolopyrimidines as shown in formula (I):and pharmaceutically acceptable derivatives thereof. The compounds are useful in the inhibition of IGF-1R.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.